Discontinuation report ACT OLMESARTAN HCT

Last updated on 2020-06-11 History
Report ID 117516
Drug Identification Number 02443120
Brand name ACT OLMESARTAN HCT
Common or Proper name OLMESARTAN/HCTZ 40/12.5MG FC TABLET
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) OLMESARTAN MEDOXOMIL HYDROCHLOROTHIAZIDE
Strength(s) 40MG 12.5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30's and 100's
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-06-08
Remaining supply date 2020-06-08
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-06-11 French Compare
v1 2020-06-11 English Compare